These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: FDG PET for giant cavernous hemangioma: important clue to differentiate from a malignant vascular tumor in the liver.
    Author: Shimada K, Nakamoto Y, Isoda H, Saito H, Arizono S, Shibata T, Togashi K.
    Journal: Clin Nucl Med; 2010 Dec; 35(12):924-6. PubMed ID: 21206221.
    Abstract:
    Giant cavernous hemangioma of the liver sometimes has a very inhomogeneous appearance with intratumoral degeneration on computed tomography or magnetic resonance imaging, and may mimic a malignant hepatic tumor, including angiosarcoma. There are many reports about F-18 fluorodeoxyglucose (FDG) uptake of angiosarcoma; however, knowledge regarding positron emission tomography findings with FDG for giant hepatic cavernous hemangioma is still limited. We herein present 2 cases of giant hepatic cavernous hemangioma in which low FDG uptake was considered helpful to differentiate from malignant hepatic tumor.
    [Abstract] [Full Text] [Related] [New Search]